Joy Tsai, MD

Assistant Professor
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• ORF34-08 - Three Versus Twelve Months of Romosozumab for Postmenopausal Osteoporosis: The Limited Duration Anabolic Therapy (LIDA) Randomized Controlled Trial

  Sunday, June 14, 2026
  3:00 PM - 3:15 PM CT

• MON-803 - Higher PTH level is associated with lower bone mass, microstructure, and strength in adults with type 1 diabetes and mild to moderate diabetic kidney disease

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT